ABIO - Oruka Therapeutics Inc.
IEX Last Trade
2.46
2.460 100.000%
Share volume: 0
Last Updated: Fri 30 Aug 2024 08:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
18%
Profitability
18%
Dept financing
3%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.99%
Return on assets
-19.56%
Return on sales
0%
Return on invested capital
128.06%
Total debt ratio
12.21%
Debt ratio change over timeo
-0.94%
Current Ratio
9.49%
Quick Ratio
0%
Cash Position Ratio
8.05%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.41%
Return on assets
-12.01%
Return on sales
0%
Return on invested capital
125.29%
Total debt ratio
10.17%
Debt ratio change over timeo
-0.92%
Current Ratio
14.57%
Quick Ratio
0%
Cash Position Ratio
14.15%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-3.95%
Return on assets
-3.83%
Return on sales
0%
Return on invested capital
134.44%
Total debt ratio
2.94%
Debt ratio change over time
-0.97%
Current Ratio
34.01%
Quick Ratio
0%
Cash Position Ratio
33.46%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-109.78%
Return on assets
-108.75%
Return on sales
0%
Return on invested capital
2.86%
Total debt ratio
-94.1%
Debt ratio change over time
-0.94%
Current Ratio
4.56%
Quick Ratio
0%
Cash Position Ratio
4.48%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABIO | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -21.99% | -3.65% | 12.3% | 7.86% |
| Return on assets | -19.56% | 3.5% | 3.6% | 4.06% |
| Return on sales | 0% | 31.31% | 41.82% | 25.03% |
| Return on invested capital | 128.06% | 4.99% | 7.81% | 1982.17% |
| Profitability | 2% | 40% | 72% | 81% |
| Total debt ratio | 12.21% | 101.15% | 75.51% | 36.43% |
| Debt ratio change over time | -0.94% | 224.03% | 6.03% | 0.39% |
| Dept financing | 3% | 50% | 19% | 9% |
| Current Ratio | 14.57% | 2.03% | 1.87% | 3.65% |
| Quick Ratio | 0% | 1.9% | 1.53% | 3.53% |
| Cash Position Ratio | 14.15% | 1.41% | 0.73% | 2.51% |
| Liquididy | 50% | 16% | 34% | 41% |
| Short-term ratios | ABIO | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -13.41% | -16.17% | 18.05% | 9.56% |
| Return on assets | -12.01% | 2.71% | 3.58% | 6.92% |
| Return on sales | 0% | 29.9% | 36.22% | 44.43% |
| Return on invested capital | 125.29% | 6.54% | 5.97% | 35.86% |
| Profitability | 25% | 28% | 60% | 70% |
| Total debt ratio | 10.17% | 99.31% | 83.77% | 27.16% |
| Debt ratio change over time | -0.92% | 851.68% | 10.97% | 1.18% |
| Dept financing | 3% | 50% | 21% | 7% |
| Current Ratio | 14.57% | 2.03% | 1.87% | 3.65% |
| Quick Ratio | 0% | 1.9% | 1.53% | 3.53% |
| Cash Position Ratio | 14.15% | 1.41% | 0.73% | 2.51% |
| Liquididy | 50% | 19% | 15% | 36% |